Goserelin depot in the treatment of premenopausal advanced breast cancer.
about
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal womenCombination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical OncologyLuteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancerLuteinizing hormone-releasing hormone analogues in early breast cancer: updated status of ongoing clinical trialsUse of goserelin in the treatment of breast cancer.The role of ovarian ablation in the management of breast cancer.Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts.Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol.Hormonal therapies in young breast cancer patients: when, what and for how long?Nocturnal Hot Flashes: Relationship to Objective Awakenings and Sleep Stage Transitions.A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.Endocrine therapy for the treatment of postmenopausal women with breast cancer.Breast cancer: beyond the cutting edge.New insights into endocrine therapy for young women with breast cancer.Bilateral Salpingo-Oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women.Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?Estrogen receptors: role in breast cancer.Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients.Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature
P2860
Q33197385-327805B4-D73D-4217-9C52-C4951EE2086DQ34568109-FC3C948A-BEA7-47CA-ADEE-78118022C0F3Q36080911-B8D5AAA6-31A2-478A-9856-DEB912D82828Q36114435-211F1BD6-167F-4E39-BEF9-2949F2EC8D28Q36114451-16F2C46F-AD8F-4732-B17A-6437741CFE20Q36235537-166FEB15-B215-4B05-8D2E-A22232E708BFQ36317136-C9A630FC-3E01-4A21-B461-117C11455DF5Q36617852-FD99A69E-25A3-49F0-8290-7F3DB3BD9A32Q36915182-7334B02D-58ED-4064-B8E1-D2774E8F04D2Q36941470-9CD7288D-0C0C-41EC-A740-DC52675C7236Q36963393-961D72BB-6187-4F63-8002-E6FD56829E77Q37033359-1EC11CF5-719F-4533-9B5F-456CC9FF3632Q37301954-EED26EF4-20BF-4463-AC9A-70D808FF8CEAQ37385376-5FAA14E3-5CE6-4AF5-B38B-1E92785B78F2Q37598890-AC86DF2D-984A-44E1-AB01-66D81720D070Q38535371-74A12105-4CF4-4EB8-9654-73DBB621AF5CQ38933076-3B217D84-9F2E-4B90-89F7-5ABBB39D3E1EQ41646589-B8320963-0778-40B2-A2C5-BA4148B5A173Q43614271-276F962F-7549-40EE-AFC7-3BF567B57CB9Q53595317-29A9A13E-3EB8-4136-8F88-21BAA88EBFB9Q54469389-501E889C-814B-4D9F-9515-C61468BF1AF3Q57108908-0029B271-801A-4C4B-9CDC-807BA6B02B6A
P2860
Goserelin depot in the treatment of premenopausal advanced breast cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@en
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@nl
type
label
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@en
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@nl
prefLabel
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@en
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@nl
P2093
P1476
Goserelin depot in the treatment of premenopausal advanced breast cancer.
@en
P2093
P304
P356
10.1016/0959-8049(92)90120-Q
P577
1992-01-01T00:00:00Z